
Age-Related Macular Degeneration Global Market Report 2025
Description
Age-Related Macular Degeneration Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on age-related macular degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for age-related macular degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The age-related macular degeneration market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Wet Age-Related Macular Degeneration (AMD); Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea; Lucentis; Avastin; Other Products
3) By Route Of Administration: Intravenous; Intravitreal
4) By Distribution Channel: Hospital Pharmacy; Specialty Pharmacy; Online Pharmacy
Subsegments:
1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections; Photodynamic Therapy; Laser Surgery
2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements; Low Vision Aids; Therapies For Geographic Atrophy
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Bayer AG; Pfizer Inc.; Bausch Health Companies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on age-related macular degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for age-related macular degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The age-related macular degeneration market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Wet Age-Related Macular Degeneration (AMD); Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea; Lucentis; Avastin; Other Products
3) By Route Of Administration: Intravenous; Intravitreal
4) By Distribution Channel: Hospital Pharmacy; Specialty Pharmacy; Online Pharmacy
Subsegments:
1) By Wet Age-Related Macular Degeneration (AMD): Anti-VEGF Injections; Photodynamic Therapy; Laser Surgery
2) By Dry Age-Related Macular Degeneration (AMD): Nutritional Supplements; Low Vision Aids; Therapies For Geographic Atrophy
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Bayer AG; Pfizer Inc.; Bausch Health Companies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Age-Related Macular Degeneration Market Characteristics
- 3. Age-Related Macular Degeneration Market Trends And Strategies
- 4. Age-Related Macular Degeneration Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Age-Related Macular Degeneration Growth Analysis And Strategic Analysis Framework
- 5.1. Global Age-Related Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Age-Related Macular Degeneration Market Growth Rate Analysis
- 5.4. Global Age-Related Macular Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Age-Related Macular Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Age-Related Macular Degeneration Total Addressable Market (TAM)
- 6. Age-Related Macular Degeneration Market Segmentation
- 6.1. Global Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Wet Age-Related Macular Degeneration (AMD)
- Dry Age-Related Macular Degeneration (AMD)
- 6.2. Global Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Eylea
- Lucentis
- Avastin
- Other Products
- 6.3. Global Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intravenous
- Intravitreal
- 6.4. Global Age-Related Macular Degeneration Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Specialty Pharmacy
- Online Pharmacy
- 6.5. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anti-VEGF Injections
- Photodynamic Therapy
- Laser Surgery
- 6.6. Global Age-Related Macular Degeneration Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration (AMD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nutritional Supplements
- Low Vision Aids
- Therapies For Geographic Atrophy
- 7. Age-Related Macular Degeneration Market Regional And Country Analysis
- 7.1. Global Age-Related Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Age-Related Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Age-Related Macular Degeneration Market
- 8.1. Asia-Pacific Age-Related Macular Degeneration Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Age-Related Macular Degeneration Market
- 9.1. China Age-Related Macular Degeneration Market Overview
- 9.2. China Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Age-Related Macular Degeneration Market
- 10.1. India Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Age-Related Macular Degeneration Market
- 11.1. Japan Age-Related Macular Degeneration Market Overview
- 11.2. Japan Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Age-Related Macular Degeneration Market
- 12.1. Australia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Age-Related Macular Degeneration Market
- 13.1. Indonesia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Age-Related Macular Degeneration Market
- 14.1. South Korea Age-Related Macular Degeneration Market Overview
- 14.2. South Korea Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Age-Related Macular Degeneration Market
- 15.1. Western Europe Age-Related Macular Degeneration Market Overview
- 15.2. Western Europe Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Age-Related Macular Degeneration Market
- 16.1. UK Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Age-Related Macular Degeneration Market
- 17.1. Germany Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Age-Related Macular Degeneration Market
- 18.1. France Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Age-Related Macular Degeneration Market
- 19.1. Italy Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Age-Related Macular Degeneration Market
- 20.1. Spain Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Age-Related Macular Degeneration Market
- 21.1. Eastern Europe Age-Related Macular Degeneration Market Overview
- 21.2. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Age-Related Macular Degeneration Market
- 22.1. Russia Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Age-Related Macular Degeneration Market
- 23.1. North America Age-Related Macular Degeneration Market Overview
- 23.2. North America Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Age-Related Macular Degeneration Market
- 24.1. USA Age-Related Macular Degeneration Market Overview
- 24.2. USA Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Age-Related Macular Degeneration Market
- 25.1. Canada Age-Related Macular Degeneration Market Overview
- 25.2. Canada Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Age-Related Macular Degeneration Market
- 26.1. South America Age-Related Macular Degeneration Market Overview
- 26.2. South America Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Age-Related Macular Degeneration Market
- 27.1. Brazil Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Age-Related Macular Degeneration Market
- 28.1. Middle East Age-Related Macular Degeneration Market Overview
- 28.2. Middle East Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Age-Related Macular Degeneration Market
- 29.1. Africa Age-Related Macular Degeneration Market Overview
- 29.2. Africa Age-Related Macular Degeneration Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Age-Related Macular Degeneration Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Age-Related Macular Degeneration Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Age-Related Macular Degeneration Market Competitive Landscape And Company Profiles
- 30.1. Age-Related Macular Degeneration Market Competitive Landscape
- 30.2. Age-Related Macular Degeneration Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Age-Related Macular Degeneration Market Other Major And Innovative Companies
- 31.1. Regeneron Pharmaceuticals Inc.
- 31.2. Amgen Inc.
- 31.3. Alimera Sciences Inc.
- 31.4. Alkeus Pharmaceuticals Inc.
- 31.5. AbbVie Inc.
- 31.6. Outlook Therapeutics Inc.
- 31.7. Biogen Inc.
- 31.8. Samsung Bioepis Co. Ltd.
- 31.9. Biocon Ltd.
- 31.10. Bio-Thera Biopharmaceutical Co. Ltd.
- 31.11. AstraZeneca plc
- 31.12. Acucela Inc.
- 31.13. Ophthotech Corporation
- 31.14. Kodiak Sciences Inc.
- 31.15. REGENXBIO Inc.
- 32. Global Age-Related Macular Degeneration Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Age-Related Macular Degeneration Market
- 34. Recent Developments In The Age-Related Macular Degeneration Market
- 35. Age-Related Macular Degeneration Market High Potential Countries, Segments and Strategies
- 35.1 Age-Related Macular Degeneration Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Age-Related Macular Degeneration Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Age-Related Macular Degeneration Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.